Sarcoidosis in patients with chronic hepatitis C virus infection -: Analysis of 68 cases

被引:114
|
作者
Ramos-Casals, M
Maña, J
Nardi, N
Brito-Zerón, P
Xaubet, A
Sánchez-Tapias, JM
Cervera, R
Font, J
机构
[1] Univ Barcelona, Serv Malalties Autoimmunes, Hosp Clin Barcelona,Sch Med, Dept Autoimmune Dis,IDIBAPS, E-08036 Barcelona, Spain
[2] Univ Barcelona, Sch Med, Hosp Clin Barcelona, IDIBAPS,Dept Pneumol, E-08036 Barcelona, Spain
[3] Univ Barcelona, Sch Med, Hosp Clin Barcelona, IDIBAPS,Dept Liver Unit, E-08036 Barcelona, Spain
[4] Hosp Univ Bellvitge, Hosp Llobregat, Dept Internal Med, Barcelona, Spain
关键词
D O I
10.1097/01.md.0000157577.69729.e6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe the clinical characteristics, the patterns of association, and the role of antiviral therapies in patients with sarcoidosis associated with chronic hepatitis C virus (HCV) infection. Sixty-eight patients were included in the Current study, 56 cases identified in the literature search plus 12 unpublished cases from our department. In 50 HCV patients, sarcoidosis appeared after starting antiviral therapy. Antiviral therapy associated with triggered sarcoidosis consisted of a-interferon monotherapy in 20 cases and combined therapy with a-interferon and ribavirin in 30. Sarcoidosis appeared during the first 6 months after starting therapy in 66% of patients. The clinical picture of sarcoidosis included predominantly pulmonary disease in 38 (76%) patients and cutaneous sarcoidosis in 30 (60%). Antiviral therapy was discontinued in 60% of patients and continued or adjusted in 14%, while sarcoidosis appeared after completed therapy in the remaining cases. Specific therapy for sarcoidosis was started in only 21 patients, mainly with oral corticosteroids. The outcome of patients was detailed in 46 cases: remission or improvement was observed in 38/46 (83%) patients, stabilization of sarcoidosis in 5/46 (11%), and reactivation of sarcoidosis after an initial improvement in 3/46 (6%). Finally, 18 treatment-naive HCV patients presented sarcoidosis, with 14/18 (87%) patients presenting with pulmonary involvement and 8/18 (44%) with Cutaneous involvement. In summary, sarcoidosis may be observed in HCV patients in 2 different situations: triggered by antiviral therapy (in 75% of cases) and unrelated to treatment. Sarcoidosis during antiviral therapy may present mainly as cutaneous or pulmonary disease, with a benign, uncomplicated evolution in more than 85% of cases. However, more complicated cases are observed, especially in HCV patients with preexisting sarcoidosis and/or with previous antiviral treatment. Clinicians should be aware of the possibility that sarcoidosis may initially manifest or be reactivated during or shortly after treatment with antiviral therapy in patients with chronic HCV infection.
引用
收藏
页码:69 / 80
页数:12
相关论文
共 50 条
  • [1] Sarcoidosis in untreated chronic hepatitis C virus infection
    Tsimpoukas, F
    Goritsas, C
    Papadopoulos, N
    Trigidou, R
    Ferti, A
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (04) : 401 - 403
  • [2] Hepatitis C virus infection in sarcoidosis
    Kakizaki, S
    Takgi, H
    Takayama, H
    Nagamine, T
    Mori, M
    [J]. HEPATOLOGY, 1998, 28 (04) : 671A - 671A
  • [3] Sarcoidosis in a woman with chronic C hepatitis virus infection: A case report
    Pereira, Eduardo Guimaraes
    Guimaraes, Tais Ferreira
    Bottino, Caroline Bertolini
    Lima, Ricardo Barbosa
    D'Acri, Antonio Macedo
    Martins, Carlos Jose
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB61 - AB61
  • [4] GB virus C hepatitis G virus infection in patients with chronic hepatitis C virus infection
    Suzuki, K
    Mizokami, M
    Saleh, MG
    Kondo, Y
    Hattori, K
    Kun, C
    Tibbs, CJ
    Williams, R
    [J]. HEPATOLOGY RESEARCH, 1998, 11 (02) : 95 - 102
  • [5] Hepatitis E in patients with chronic hepatitis C virus infection
    Bricks, G.
    Senise, J.
    Pott, H.
    Grandi, G.
    Passarini, A.
    Caldeira, D.
    Carnauba, D.
    de Moraes, H. A.
    Granato, C. F. H.
    Castelo, A.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 376 - 376
  • [6] Sarcoidosis in tattoos in chronic hepatitis virus C
    Kluger, Nicolas
    Aractingi, Selim
    [J]. PRESSE MEDICALE, 2006, 35 (11): : 1668 - 1669
  • [7] Hepatitis C virus superinfection in patients with chronic hepatitis B virus infection
    Yun-Fan Liaw
    [J]. Journal of Gastroenterology, 2002, 37 : 65 - 68
  • [8] Hepatitis C virus superinfection in patients with chronic hepatitis B virus infection
    Liaw, YF
    [J]. JOURNAL OF GASTROENTEROLOGY, 2002, 37 (Suppl 13) : 65 - 68
  • [9] Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection
    Dahal, Sumit
    Upadhyay, Smrity
    Banjade, Rashmi
    Dhakal, Prajwal
    Khanal, Nabin
    Bhatt, Vijaya Raj
    [J]. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2017, 9
  • [10] Seizures in patients with chronic hepatitis C virus infection
    Mai, AM
    Sirven, JI
    Drazkowski, JF
    Noe, KH
    Vargas, H
    [J]. NEUROLOGY, 2006, 66 (05) : A163 - A163